Drug Information Association Logo
Corporate Tagline

DIA’s 8th Annual Conference: The New Clinical Research Environment in India: Implications and Opportunities

Oct 24 2013 10:15AM - Oct 26 2013 5:30PM | Nimhans Convention Center 1st Main Road,Someshwaranagar,Hombegowda Nagar Bangalore 560029 KA India

« Back to Listing

Overview 

The pharmaceutical industry is at an inflexion with momentous changes staring it in the face. In India too, issues with investment, research, and intellectual property indicate a new environment that has both implications and opportunity. The clinical research environment, in particular, has seen ground-shifting changes. New regulations have made the pursuit of clinical development in India extremely challenging. At the same time, demand for services in the regulation-free domains of remote data processing and IT-enabled offerings is growing at an unprecedented scale. A section of the Indian pharmaceutical industry is at the threshold of entry into uncharted territories with global development of innovative assets and biosimilars, even as it braces for headwinds from a struggling global economy and more demanding regulatory requirements. Scientific advances at the genetic and molecular level and enhanced public and non-profit funding are enabling new approaches to public health concerns.

This conference will provide a forum for academia, industry, regulators and researchers to come together to discuss the new environment for health care product development in India – the challenges and the opportunities. Participants will hear about how their peers are coping with new regulations and how they are planning to realize the promise of emerging opportunities.

Featured Topics 

  • Direction, outlook and vision for health related research in India
  • Review of recent changes in regulations and their implications
  • Challenges to global development and commercialization ex-India
  • New opportunities for India-centric global delivery solutions
  • Global benchmarks in health care research regulations
  • Patient-centric endeavors for awareness and ethics of research

Who Should Attend 

Professionals, researchers and clinicians involved in drug discovery and development and regulatory affairs, eg.:

  • Drug development and clinical research managers and associates
  • Pharmaceutical physicians and medical directors
  • Drug safety and drug surveillance personnel
  • Professionals engaged in discovery research
  • Clinical pharmacology scientists
  • Pharmacologists
  • Regulatory affairs managers
  • Regulators
  • Academic scientists
  • Biostatisticians
  • Data managers
  • Medical writers
  • Outsourcing and marketing managers
  • IT professionals

Hotel & Travel 

Attendees should make airline reservations as early as possible to ensure availability.
Nearest Airport: Rajiv Gandhi International Airport, Bangalore.

VENUE:
NIMHANS Convention Center | Bangalore, India
1st Main Road,Someshwaranagar, Hombegowda Nagar, Bangalore, Karnataka, 560029

HOTEL:
To avail special negotiated rates, please mention your participation in the DIA Conference at the time of booking.

Contact Information 

Meeting Manager:

Manoj Trivedi, Senior Manager Marketing and Program Development, DIA India
Cell: +91-98-1977-7493
Phone: +91-22-6765-3226
Email: Manoj.Trivedi@diaindia.org

Featured Speaker 

Previous Next

Program Committee 

Previous Next

Agenda  

Day 1 Thursday, October 24, 2013

  • 10:15AM - 10:45AM

    Opening Ceremony & Exhibition Opening
  • 10:45AM - 11:15AM

    Guest of Honor

    Speaker(s):

    • Representative Invited
      United States
    • M. K. Bhan, MD,PhD
      Former Secretary, Department of Biotechnology (DBT)
      Government of India, India
    • B.R. Jagashetty
      Drugs Controller
      Drug Control Department, India
  • 11:15AM - 11:45AM

    Keynote 1

    Speaker(s):

    • The New Clinical Research Environment in India – Implications and Opportunities
      Padmashree Prof. Ranjit Roy Chaudhury
      Chairman, Task Force for Clinical Research
      Apollo Hospitals Group, India
  • 11:45AM - 12:15PM

    Keynote 2

    Speaker(s):

    • The Future Will Be Here
      Anu Acharya
      CEO
      Mapmygenome.in, India
  • 1:30PM - 3:00PM

    Session 1: Vaccine Development – A Challenge Like No Other


    Session Chair(s):

    • No-image M. K. Bhan, MD,PhD
      Former Secretary, Department of Biotechnology (DBT)
      Government of India, India

    Approximately 15% of the disease burden in India, and most childhood deaths, are potentially vaccine preventable. Speakers in this session will address the imperatives for India in vaccine development, summarize the collaborative efforts across academia, industry, government and philanthropic organizations, speak about the unique challenges of vaccine development, and examine the risks and benefits to patients participating in vaccine trials.

    Speaker(s):

    • Disease Burden and the Imperatives for Vaccine Development in India
      Gagandeep Kang
      Professor of Microbiology, Head, The Wellcome Trust Research Laboratory
      Department of Gastrointestinal Sciences, CMC, Vellore, India
    • Unique Challenges in Vaccine Development
      Rajat Goyal
      Country Director
      IAVI, India
    • Myths and Realities – How Patients Benefit from Vaccine Trials
      Temsunaro Rongsen Chandola
      Centre for Health Research & Development, Society for Applied Studies, India
  • 3:30PM - 5:30PM

    Session 2: Health Outcomes and Policies for the Developing World

    Speaker(s):

    • Health Outcomes and Policies for the Developing World
      Raj Shankar Ghosh
      Interim Deputy Director, Vaccines Delivery
      Bill and Melinda Gates Foundation, India
    • Health and Demographic Surveillance Systems (HDSS) – A Platform for Public Health Research
      Ashish Bavdekar
      Consultant in Pediatric Research Department of Pediatrics & Vadu HDSS
      Vadu Rural Health Program, KEM Hospital Research Centre, India
    • Innovation in Technology: Benefits in Public Health
      Tarun Vij
      Country Program Leader
      PATH, India
    • Panel Discussion: Health Outcomes and Policies for the Developing World
      Harish Iyer
      CEO
      Shantha Biotech, India
    • Panel Discussion: Health Outcomes and Policies for the Developing World
      Tarun Vij
      Country Program Leader
      PATH, India
    • Panel Discussion: Health Outcomes and Policies for the Developing World
      Ashish Bavdekar
      Consultant in Pediatric Research Department of Pediatrics & Vadu HDSS
      Vadu Rural Health Program, KEM Hospital Research Centre, India

Day 2 Friday, October 25, 2013

  • 9:30AM - 11:00AM

    Session 1A: The New Clinical Research Environment

    Speaker(s):

    • The New Clinical Research Environment
      Anil Seth
      Director Clinical Research
      Eli Lilly, India
    • Implications, Impact and Outcome
      Mubarak Naqvi, MD
      Senior Director, Clinical Study Unit
      Sanofi Synthélabo, India
    • Direction and Outlook
      Suresh Ramu
      Co-founder and CEO
      Cytespace, India
  • 9:30AM - 11:00AM

    Session 1B: Global Development of Biosimilars

    Speaker(s):

    • Global view on Biosimilar Development Strategy
      Andrew Rankin, PhD
      Executive Vice President, Operations
      Qforma, United States
    • India and the Biosimilars Opportunity
      Arvind Raghunath
      Director
      Prescient Healthcare Group, India
    • Program Design Challenges and Case studies
      Charu Manaktala
      Medical Director, Biosimilars
      Quintiles, India
  • 9:30AM - 11:00AM

    Session 1C: Discovery, Pre-Clinical, Early Development, Phase 1, BA/BE, Labs

    Speaker(s):

    • Crowd Sourcing in Drug Development - Will it work?
      Sowmyanarayan Srinivasan, MBA
      Cognizant Technology Solutions India P Ltd, India
    • Drug Discovery and Lead Optimisation
      K.K. Bhagchandani
      Director of Business Strategy & Sales (Asia Pacific)
      Advanced Chemistry Development, Inc. (ACD/Labs), India
    • Crowd Sourcing in Drug Development - Will it work?
      Zakir Thomas
      Open Source Drug Discovery Initiative (OSDD), India
  • 9:30AM - 11:00AM

    Session 1D (DIA-AIMWA): Lean Medical Writing: Practical Applications for Authoring Clinical Study Reports


    Session Chair(s):

    • Paul Sokol, PhD
      Director
      Johnson & Johnson Prd., United States
    • Helle-Mai Gawrylewski, MA
      Senior Director, Medical Affairs and Alliance Management in Medical Writing
      Janssen Research & Development, LLC, United States

    Session 1D (DIA-AIMWA): Lean Medical Writing: Practical Applications for Authoring Clinical Study Reports

    Speaker(s):

    • Lean Principles
      Paul Sokol, PhD
      Director
      Johnson & Johnson Prd., United States
    • Applications of Lean Principles in Devising Medical Writing Strategies
      Neera Shetty
      Deputy General Manager
      Cognizant Technology Solutions, India
    • Implementing Lean CSR Principles: A Medical Writer’s Perspective
      Ambika Subramanian
      Lead Medical Writer & Project Coordinator, Scientific Writing & RA
      Sciformix Technologies Private Limited, India
    • Questions and Open Discussion – Take Away Points
      Helle-Mai Gawrylewski, MA
      Senior Director, Medical Affairs and Alliance Management in Medical Writing
      Janssen Research & Development, LLC, United States
  • 11:30AM - 1:00PM

    Session 2A: Building the Framework - WIP

    Speaker(s):

    • Redesigning Informed Consent
      Madeline Ducate
      Executive Vice President, Global Operations
      Pharm-Olam International Ltd, United States
    • Site Accreditation Framework
      Shoibal Mukherjee
      Vice President, CMO (India) & Head Asia Medical Sciences Group
      Quintiles, India
    • Enhancing CR Capability in India
      Vivek Ahuja
      Director
      PATH, India
  • 11:30AM - 1:00PM

    Session 2B: Patient Awareness, Advocacy and Informed Concent

    Speaker(s):

    • Patient Awareness,Advocacy and Informed Consent
      Radhika Bobba
      Regional Director, India and Far East
      PSI CRO, India
    • Patient Awareness Program Support and Advocacy
      Durhane Wong-Rieger, PhD,MA
      President & CEO
      Canadian Organization For Rare Disorders, Canada
    • Patient Involvement in Clinical Trials: Canadian Initiatives
      Ronald Heslegrave
      Chief of Research
      William Osler Health System, Canada
    • Update on PARTAKE (Public Awareness of Research for Therapeutic Advancements through Knowledge and Empowerment)
      Nandini Kumar
      Former Deptuy Director General Sr. Grade
      Co-Investigator NIH Project, India
  • 11:30AM - 1:00PM

    Session 2C: IT In Clinical Records and Collaboration

    Speaker(s):

    • Technology @ Clinical Trial Sites
      Lalit Pai
      Co-founder
      Cytespace, India
    • A Prescription for Value: A Successful formula for Applying Big Data in Healthcare
      Sudeep Pattnaik
      Vice President, IT
      Quintiles, United States
    • Data Integration and Analytics in Clinical Development
      Subbaraju Sagi
      CEO
      TechSol, United States
  • 11:30AM - 1:00PM

    Session 2D (DIA-AIMWA): Interactive Workshop on Lean Writing

    Speaker(s):

    • Session 2D (DIA-AIMWA): Interactive Workshop on Lean Writing
      Paul Sokol, PhD
      Director
      Johnson & Johnson Prd., United States
  • 2:00PM - 3:30PM

    Session 3A: Evolving Pharmaceutical Regulations in the Region

    Speaker(s):

    • Clinical Research Environment and Regulations in Sri Lanka
      Asita de Silva
      Head, Clinical Trials Unit
      University of Kelaniya, Sri Lanka
    • Drug and Cosmetics Amendment Bill 2013
      Alishan Naqvee
      Partner
      LexCounsel, India
    • The Bill: A Critical Analysis
      Shoibal Mukherjee
      Vice President, CMO (India) & Head Asia Medical Sciences Group
      Quintiles, India
  • 2:00PM - 3:30PM

    Session 3B: India as an Innovation and Deliver Hub

    Speaker(s):

    • Drug Discovery - How is India doing?
      J.B. Gupta
      Senior Vice President
      GVK Biosciences, India
    • Remote Clinical Operations – Opportunities and Challenges
      Hemant Rehani
      Vice President and Head, CDS
      Quintiles, India
    • The World of Remote Bio-signals Processing
      Arjun Kalyanpur
      CEO & Chief Radiologist
      Image Core Lab and Teleradiology Solutions, India
  • 2:00PM - 3:30PM

    Session 3C: Risk-based Monitoring

    Speaker(s):

    • Success Story of RBM for a leading Biotech Sponsor
      Jagadeesh Rudraswamymath
      Director CDM, Global Data and Safety Monitoring
      Quintiles, India
    • RBM - Significant Cost Savings along with Effective and Efficient Monitoring
      Rajesh Jain, DrMed
      Director Operations
      Cognizant Technology Solution, India
    • IT Solution Framework for Enabling RBM
      T. Raghu Babu
      Deputy General Manager, Operations
      HCL Technologies Ltd., India
  • 2:00PM - 3:30PM

    Session 3D (DIA-AIMWA): Quality Documents: From Beginning to End


    Session Chair(s):

    • Helle-Mai Gawrylewski, MA
      Senior Director, Medical Affairs and Alliance Management in Medical Writing
      Janssen Research & Development, LLC, United States
    • Roopa Basrur
      Director, Medical Writing Services India
      PAREXEL International, India

    Session 3D (DIA-AIMWA): Quality Documents: From Beginning to End

    Speaker(s):

    • SPIRIT: Initiative to Improve Clinical Trial Protocols Introduction and References
      Helle-Mai Gawrylewski, MA
      Senior Director, Medical Affairs and Alliance Management in Medical Writing
      Janssen Research & Development, LLC, United States
    • Effective Project Management is Necessary to Produce High Quality Documents
      Garima Pallavi
      Scientific Writer
      GlaxoSmithKline, India
    • Robust Document Reviews – Quality and Peer Review
      Anupama Ramkumar
      Director
      Arkus Clinical Trial Support Solutions, India
  • 4:00PM - 5:00PM

    Session 4: Media, Activism and Judicial Intervention in Clinical Researh

    Speaker(s):

    • Penary Session: Media, Activism and Judicial Intervention in Clinical Research
      Anil Seth
      Director Clinical Research
      Eli Lilly, India
    • Alishan Naqvee
      Partner
      LexCounsel, India
    • Durhane Wong-Rieger, PhD,MA
      President & CEO
      Canadian Organization For Rare Disorders, Canada
    • Poonam Bagal
      Founder Chairman
      Cankids...KidsCan, India
    • Sanjay Pai
      Consultant Pathologist, Pathology and Laboratory Head
      Medicine Columbia Asia Referral Hospital, India
    • Hari Pulakkat
      Senior Editor
      The Economic Times, India
    • Seema Singh
      Senior Editor
      Forbes India, India

Day 3 Saturday, October 26, 2013

  • 9:30AM - 11:00AM

    Session 5AB1: Recent Developments in Clinical Trials Data Sharing

    Speaker(s):

    • Clinical Trials Data Transparency Initiatives: Background and Current Developments
      Mark Barnes
      Partner
      Ropes & Gray, LLP, United States
    • Clinical Trials Data Transparency Initiatives: Background and Current Developments
      Arun Mishra
      Senior Director, Global Regulatory Affairs
      GSK, United Kingdom
  • 9:30AM - 11:00AM

    Session 5C: Manufacturing, Supply Chain, Regulatory, Safety and Risk Management

    Speaker(s):

    • Challenges in Clinical Trial Supply Management
      Veerendra Kumar
      Senior Director
      PAREXEL, India
    • Impact of New EU Pharmacovigilance Legislations on the Industry
      Sanjeev Miglani, MD
      Head Pharmacovigilance US Operations
      Apcer Pharma Solutions, Inc., United States
    • Role of Technology in Meeting Dynamic Regulatory Environment
      Rajeshwari Bijur
      Associate Director, Process Center, Global Data and Safety Monitoring
      Quintiles, India
  • 9:30AM - 11:00AM

    Session 5D (DIA-AIMWA): Medical Writing Competency Building


    Session Chair(s):

    • Vatsal Shah
      Vice President & Global Head, Medical Writing and Pharmacovigilance
      SIRO Clinpharm, India
    • Rajesh Kher
      Director, Medical Affaris & Alliance Management (Asia Pacific)
      Janssen Research & Development, LLC, India

    Session 5D (DIA-AIMWA): Medical Writing Competency Building

    Speaker(s):

    • CARE – An Interactive Program for Enhancement of Skill Sets for Medical Writers
      Seema Gurbani
      Assistant Manager, Medical Writing
      Tata Consultancy Services, India
    • CARE – An Interactive Program for Enhancement of Skill Sets for Medical Writers
      Rajesh Kher
      Director, Medical Affaris & Alliance Management (Asia Pacific)
      Janssen Research & Development, LLC, India
    • Developing Skills for Robust Document Reviews - Quality and Peer Review
      Bindu Narang
      Director
      Sciformix Corporation, India
    • Effective Mentoring and Coaching in Medical Writing
      Vatsal Shah
      Vice President & Global Head, Medical Writing and Pharmacovigilance
      SIRO Clinpharm, India
  • 9:30AM - 11:00AM

    Session 5AB2: Compensation for Injuries to Participants in Research: A Trans-National Perspective


    Session Chair(s):

    • Mark Barnes
      Partner
      Ropes & Gray, LLP, United States

    Speaker(s):

    • Impact of Recent Regulations: Ethics Committee Perspective
      Urmila Thatte
      Director, FERCI, Prof. and Head, Deptartment of Clinical Pharmacology
      KEM Hospital, India
    • Suneela Thatte presentation
      Suneela Thatte
      Indian Society of Clinical Research (ISCR), India
    • Compensation for Clinical Trial Injuries
      Mark Barnes
      Partner
      Ropes & Gray, LLP, United States
  • 11:30AM - 1:00PM

    Session 6A (DIA-FERCI): The New Ethics Committee

    Speaker(s):

    • EC Perspectives
      Urmila Thatte
      Director, FERCI, Prof. and Head, Deptartment of Clinical Pharmacology
      KEM Hospital, India
    • Way to Accreditation of IECs Sponsor’s perspective - Sponsor's perspective
      Viraj Suvarna
      Head Medical Affairs and Research
      Pfizer Ltd, India
    • Investigator Perspective
      Sanjay Pai
      Consultant Pathologist, Pathology and Laboratory Head
      Medicine Columbia Asia Referral Hospital, India
    • Way to Accreditation of IEC
      Nandini Kumar
      Former Deptuy Director General Sr. Grade
      Co-Investigator NIH Project, India
  • 11:30AM - 1:00PM

    Session 6B: Risk-based Approach to Monitoring CR

    Speaker(s):

    • Risk-based Approach to Monitoring CR
      Sunita Zalani, PhD,MS
      Vice President, Global Regulatory Affairs
      Onyx Pharmaceuticals, Inc., United States
    • Risk-based Approach to Monitoring CR
      Chirag Trivedi
      Deputy Director, Project Management & Strategic Initiatives
      Sanofi, India
  • 11:30AM - 1:00PM

    Session 6C: Sales and Markeing; Analytics

    Speaker(s):

    • SMAC (Social Media, Mobility, Analytics and Cloud) or Newer Technologies
      Dinesh Chindarkar
      Co-Founder & Vice President - Operations
      MediaMedic Communications, India
    • Representative Invited
      Editor
      MedicinMan, India
    • Leveraging Competitive Intelligence for Development of Commercial Strategy
      Rajesh Kuppuswamy
      Senior Director
      Cognizant, India
  • 11:30AM - 1:00PM

    Session 6D (DIA-AIMWA): The New Clinical Research Environment in India: Implications & Opportunities in Biostatistics and Statistical Programming


    Session Chair(s):

    • Arghya Chattopadhyay
      Vice President, Biostatistics & Programming
      Tata Consultancy Services, India
    • Reshma Chowdhry
      Domain Consultant, Biostatistics & Programming
      Tata Consultancy Services, India

    Session 6D (DIA-AIMWA): The New Clinical Research Environment in India: Implications & Opportunities in Biostatistics and Statistical Programming

    Speaker(s):

    • Beyond Tables, Listings and Figures
      Nithiyanandhan Ananthakrishnan
      Senior Manager, SAS Programming
      ICON Clinical Research , India
    • A Brief Review of Phase 1 and Clinical Pharmacology Statistics in Clinical Drug Development
      Nand Kishore Rawat
      Lead Statistician
      Cytel Statistical Software & Services Pvt. Ltd., India
    • Biostatistics and Programming – Outsourcing Landscape Opportunities and Challenges
      Tushar Sakpal
      Sr. Statistical Programmer
      PharmaNet Clinical Services Pvt. Ltd., India
    • New Clinical Research Environment in India
      Tommy Pedersen
      Head, Biostatistics
      Quintiles, India
  • 2:00PM - 3:30PM

    Session 7A: Industry-Regulator Interactions – Global Clinical Review Practices


    Session Chair(s):

    • No-image Arun Mishra
      Senior Director, Global Regulatory Affairs
      GSK, United Kingdom

    This session will focus on examples of robust industry regulator interactions during the regulatory review process in key developing and developed countries across the globe. Speakers will demonstrate how collaboration makes for greater effectiveness and efficiency of the review process and aids improved decision-making.

    Speaker(s):

    • Elements of an Effective and Efficient Review Process – Examples from Key Emerging Markets, EU, US and Switzerland
      Chet Elias
      Director, GRAAS JAPAC
      Amgen, United States
    • Engaging Regulatory Authorities During Complex Drug Development – Scientific Advice Process in Emerging Markets
      Arun Mishra
      Senior Director, Global Regulatory Affairs
      GSK, United Kingdom
    • Sound Clinical Reviews/Mind Over Matter - Any Role for the Heart
      Aamir Shaikh
      Founder
      Assansa, India
  • 2:00PM - 3:30PM

    People Management in High Performing Organisations


    Session Chair(s):

    • Sabita Rebecca
      Partner
      Leader Prospects India Pvt. Ltd., India

    As the size of organizations grow and competition for talent in the life sciences becomes more acute, attracting and retaining the best talent is key to managing growth. Speakers with experience in the domain will discuss issues of workforce management in clinical research, from techniques in recruitment to retention, engagement and talent management. Session under development.

    Speaker(s):

    • Clinical ‘Re-search’ for Talent
      Suresh Sharma
      Associate Vice President
      Tata Consultancy Services, United States
    • Employee Retention and Engagement
      Krathish Bopanna
      President & CEO
      Semler Research Center, India
    • Career Path and Development
      Anand Eswaraiah
      Head of Clinical Development & Regulatory Affairs
      Clinigene International Limited, India
  • 2:00PM - 3:30PM

    Session 7C: SMAC (Social Media, Mobility, Analytics and Cloud) or New Technologies

    Speaker(s):

    • Social Media, Digital and Analytics for Pharma
      Dinesh Chindarkar
      Co-Founder & Vice President - Operations
      MediaMedic Communications, India
    • Building the Life Sciences Ecosystem on the Cloud
      Sanjeev Singh
      Director
      Aris Global, India
  • 2:00PM - 3:30PM

    Session 7D (DIA-AIMWA): Open Discussion Forum: How Can We Take the Medical Writing Profession to the Next Level in India?

    Speaker(s):

    • Session 7D (DIA-AIMWA): Open Discussion Forum: How Can We Take the Medical Writing Profession to the Next Level in India?
      Radhika Bobba
      Regional Director, India and Far East
      PSI CRO, India
    • Vatsal Shah
      Vice President & Global Head, Medical Writing and Pharmacovigilance
      SIRO Clinpharm, India
    • Bindu Narang
      Director
      Sciformix Corporation, India
    • Paul Sokol, PhD
      Director
      Johnson & Johnson Prd., United States
    • Helle-Mai Gawrylewski, MA
      Senior Director, Medical Affairs and Alliance Management in Medical Writing
      Janssen Research & Development, LLC, United States
    • Roopa Basrur
      Director, Medical Writing Services India
      PAREXEL International, India
    • Pooja Phogat
      Senior Manager, Medical Writing & Medical Information
      Kinapse Ltd., United Kingdom
    • Sheetal S. Ingole
      Senior Manager, Medical Affairs & Pharmacovigilance
      Ecron Acunova, India
  • 4:00PM - 5:30PM

    Session 8: Panel Discussion and Closing

    Speaker(s):

    • The New Clinical Research Environment in India: Implications and Opportunities
      Shoibal Mukherjee
      Vice President, CMO (India) & Head Asia Medical Sciences Group
      Quintiles, India

Exhibits  

The 8th Annual Conference offers interested companies many options to promote their products and services. Please see the Supporting Opportunities flyer for more information and to register.

Useful Links:

______________________________

Thank you to our Media Partners













  • Aris Global Software Pvt. Ltd.
  • Cognizant
  • ICON Clinical Research
  • Oracle India Pvt. Ltd
  • PAREXEL International India Pvt. Ltd.
  • Pharm-Olam International (india) Pvt Ltd
  • Quest Diagnostics
  • Quintiles Research (India) Private Ltd.
  • SIRO Clinpharm
  • Tata Consultancy Services
  • the Uppsala Monitoring Centre
  • Vitalograph

Registration Fees 

Other Fees

Charitable Nonprofit/Academia Nonmember
Rs6000.00

Member

Member Standard
Rs10000.00

Non-Member

NonMember Standard
Rs12000.00
Group Discounts

Register 10 from your company and receive the 11th FREE! Contact our group discount representative for details or call +91.98.2058.7798


*A limited number of student registrations are available.
A student is an undergraduate/graduate who can document enrollment in a Signature accredited, degree granting, academic program. Please send completed registration form, copy of student identification, and payment.


CANCELLATION POLICY: Cancellations must be in writing and received on or before October 10, 2013.
Registrants who do not cancel in writing by that date and do not attend the event will be responsible for the full registration fee paid. Registrants are responsible for cancelling their own hotel and airline reservations. If the event is cancelled, DIA is not responsible for any airfare, hotel or other costs incurred by registrants. Upon cancellation, the administrative fee that will be withheld is 75% of the registration fee.

(All refunds will be issued in the currency of original payment.)

Register Online
« Back to Listing Back To Top